Latest Bid :
–
|
Latest Ask :
–
|
High Today :
–
|
Low Today :
–
|
This Years High :
–
|
This Years Low :
–
|
Volume :
–
|
MKT Cap :
–
|
Stock Splits and Consolidations
30/05/2018 – Stock Consolidation 50.000:1.000
Oxford Biomedica Overview
Oxford Biomedica develops innovative new IP-protected , LentiVector® based therapies, leveraging our internal research expertise and know-how. We select patient-centric product candidates and progress these through proof-of-concept, and into early clinical development, before either seeking third-party funding for full development and commercialisation or to develop further in-house.
Latest Oxford Biomedica Tips
Oxford Biomedica Data Charts
Latest Bid :
–
|
Latest Ask :
–
|
High Today :
–
|
Low Today :
–
|
This Years High :
–
|
This Years Low :
–
|
Volume :
–
|
MKT Cap :
–
|
Oxford Biomedica Overview
Oxford Biomedica develops innovative new IP-protected , LentiVector® based therapies, leveraging our internal research expertise and know-how. We select patient-centric product candidates and progress these through proof-of-concept, and into early clinical development, before either seeking third-party funding for full development and commercialisation or to develop further in-house.
Latest Oxford Biomedica Tips
Stock Splits and Consolidations
30/05/2018 – Stock Consolidation 50.000:1.000